Robert D. Nerenz, PhD, DABCC, FAACC

Publications

• Clinical decision support improves autoimmune/paraneoplastic antibody panel utilization.

  (Nerenz RD, Hooshmand SI, Jackowiak E, Shirilla D, Yang Y, Yang K, Obeidat AZ.) Am J Clin Pathol. 2024 Sep 10 PMID: 39255415 09/10/2024

• Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay.

  (Earll E, Javorsky BR, Sarvaideo J, Straseski JA, Nerenz RD.) J Endocr Soc. 2024 Apr 06;8(6):bvae069 PMID: 38698869 PMCID: PMC11065352 05/03/2024

• Commentary on Severe Hypokalemia Associated with Paralysis after a Large Carbohydrate Intake following Exercise.

  (Nerenz RD.) Clin Chem. 2024 Apr 03;70(4):588 PMID: 38565212 04/03/2024

• Commentary on Low Cortisol in a Cushingoid Patient.

  (Nerenz RD.) Clin Chem. 2023 Jun 01;69(6):562-563 PMID: 37258488 06/01/2023

• Persistent Hypercalcemia: Choose Your Testing Strategy Carefully.

  (Sharag Eldin R, Shaker J, Stachowiak S, Nerenz RD.) Clin Chem. 2023 Apr 03;69(4):330-335 PMID: 37010999 SCOPUS ID: 2-s2.0-85151804365 04/04/2023

• Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization.

  (Tolan NV, Krasowski MD, Mathias PC, Wiencek JR, Babic N, Chai PR, Chambliss AB, Choucair I, Demetriou CA, Erickson TB, Feldhammer M, French D, Hayes BD, Kang P, El-Khoury JM, Knezevic CE, Monte A, Nerenz RD, Okorodudu AO, Roper SM, Saitman A, Thiriveedhi V, Uljon SN, Vest A, Woodworth A, Yu M, Melanson SEF.) Clin Toxicol (Phila). 2023 Apr;61(4):248-259 PMID: 37129223 PMCID: PMC10793079 05/02/2023

• Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population.

  (Williams GR, Tsongalis GJ, Lewis LD, Barney RE, Cook LJ, Aaron Geno K, Nerenz RD.) J Appl Lab Med. 2023 Mar 06;8(2):251-263 PMID: 36611001 PMCID: PMC10539040 01/08/2023

• Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance.

  (Nerenz RD, Hubbard JA, Cervinski MA.) Clin Lab Med. 2022 Dec;42(4):687-704 PMID: 36368790 PMCID: PMC9651919 11/12/2022

• An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.

  (Geno KA, Badea A, Lynch KL, Jannetto P, Hubbard JA, Nerenz RD, Cervinski MA.) J Appl Lab Med. 2022 Oct 29;7(6):1318-1328 PMID: 36036092 08/30/2022

• AACC Guidance Document on the Use of Point-of-Care Testing in Fertility and Reproduction.

  (Nichols JH, Ali M, Anetor JI, Chen LS, Chen Y, Collins S, Das S, Devaraj S, Fu L, Karon BS, Kary H, Nerenz RD, Rai AJ, Shajani-Yi Z, Thakur V, Wang S, Yu HYE, Zamora LE.) J Appl Lab Med. 2022 Sep 01;7(5):1202-1236 PMID: 36047824 09/02/2022

• Reevaluating the Icterus Index Cutoff of a Jaffé Creatinine Method.

  (Alvarez YF, Kelliher MT, Hubbard JA, Nerenz RD, Cervinski MA.) J Appl Lab Med. 2022 Sep 01;7(5):1151-1157 PMID: 35899580 07/29/2022

• Commentary on Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough.

  (Nerenz RD.) Clin Chem. 2022 Sep 01;68(9):1133 PMID: 35869936 07/24/2022